drugset / Trial / NCT05197257
68Ga-PSMA-11 PET in Patients With Prostate Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
Patients will receive a single dose of 68Ga-PSMA-11 and undergo a PET/CT or PET/MRI imaging study.
Timeline
- Start
- 2021-09-29
- Primary completion
- 2022-04-14
- Completion
- 2022-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ga-PSMA-11 | Diagnostic / imaging agent | 100 mbq | Intravenous |
| Subject | Ga-PSMA-11 | Diagnostic / imaging agent | 300 mbq | Intravenous |